Stay updated on Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Fallopian tube cancer as a listed condition on the study page and updated the page revision to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-15T14:26:12.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Minor site maintenance: Revision: v3.4.1 added and Revision: v3.4.0 removed; no effect on study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T05:24:43.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    This update adds a glossary toggle and updates certain metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted) and the revision to v3.4.0, with minor labeling adjustments for No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T00:21:58.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:51:32.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Locations section expanded with numerous sites across US states and international regions, detailing where the trial is conducted.
    Difference
    2%
    Check dated 2025-12-19T07:32:00.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page shows a minor revision label update from v3.3.1 to v3.3.2. This change does not affect content or functionality of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T00:31:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.